These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16774614)

  • 1. Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents.
    Battelino T
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():20-4. PubMed ID: 16774614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renaissance of insulin pump treatment in childhood type 1 diabetes.
    Tamborlane WV; Swan K; Sikes KA; Steffen AT; Weinzimer SA
    Rev Endocr Metab Disord; 2006 Sep; 7(3):205-13. PubMed ID: 17160722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII).
    Fisher LK
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():11-4. PubMed ID: 16774612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
    Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
    Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Sikes KA; Steffen AT; Tamborlane WV
    Pediatr Clin North Am; 2005 Dec; 52(6):1677-88. PubMed ID: 16301088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time.
    Aristizábal N; Ramírez A; Hincapié-García J; Laiton E; Aristizábal C; Cuesta D; Monsalve C; Hincapié G; Zapata E; Abad V; Delgado MR; Torres JL; Palacio A; Botero J;
    Endocrinol Nutr; 2015 Nov; 62(9):451-7. PubMed ID: 26521154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
    Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes.
    Mitchell K; Johnson K; Cullen K; Lee MM; Hardy OT
    Diabetes Technol Ther; 2013 Jul; 15(7):591-5. PubMed ID: 23799273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy.
    Raile K; Noelle V; Landgraf R; Schwarz HP
    J Pediatr Endocrinol Metab; 2002 May; 15(5):607-12. PubMed ID: 12014519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in children and adolescents with type 1 diabetes.
    Malik FS; Taplin CE
    Paediatr Drugs; 2014 Apr; 16(2):141-50. PubMed ID: 24458650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
    Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
    Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.